Related Experiment Video
Updated: Feb 27, 2026

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.7K
Chronic Recurrent Multifocal Osteomyelitis in a 9-year-old Boy.
Abdolreza Malek1, Mohammadhassan Aelami1, Narges Afzali1
1Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
The Archives of Bone and Joint Surgery
|June 29, 2017
Summary
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare inflammatory bone disorder. This case study highlights successful treatment with anti-inflammatory drugs, avoiding corticosteroids.
Area of Science:
- Pediatric rheumatology
- Orthopedics
- Immunology
Background:
- Chronic recurrent multifocal osteomyelitis (CRMO) is a rare aseptic, auto-inflammatory bone disorder.
- CRMO diagnosis is often a diagnosis of exclusion, crucial in pediatric chronic inflammatory bone lesions.
- It presents with bone pain, potentially with fever, and is unresponsive to antibiotics but improves with anti-inflammatory agents.
Observation:
- A nine-year-old boy presented with recurrent upper and lower extremity pain, mild fever, and cervical lymphadenopathy.
- He reported recent bone pain and weight loss.
- Biopsy and bone scan confirmed the diagnosis of CRMO.
Findings:
- The patient was treated with Naproxen and Pamidronate.
- This therapeutic approach led to significant clinical improvement.
- The child returned to normal activities without the need for corticosteroids.
Implications:
- This case underscores the efficacy of non-corticosteroid anti-inflammatory and bone-modifying agents in managing CRMO.
- Early diagnosis and appropriate treatment can lead to favorable outcomes in pediatric CRMO.
- CRMO management may not always require immunosuppressive or corticosteroid therapies.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
336
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
Acute Pyelonephritis II: Diagnostic Studies and Management
532
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
532
Pharmacokinetics in Pediatric Patients: Drug Metabolism
289
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Tonsillitis II: Management
480
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
480
